7827 HanchorBio Inc. TWSE · Taiwan

HanchorBio (7827) news

HanchorBio Inc. is a public biotech or pharmaceutical company listed on TWSE under the ticker 7827, recorded under Taiwan. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest HanchorBio news

We have not published a story on HanchorBio yet. When there is news, it will appear here.

Questions about HanchorBio

What is the ticker symbol of HanchorBio?

HanchorBio Inc. trades under the ticker 7827 on TWSE.

Where is HanchorBio listed?

HanchorBio Inc. is listed on TWSE.

Which country or territory is HanchorBio listed under?

Our directory records HanchorBio Inc. under Taiwan.

What does HanchorBio do?

Our directory classifies HanchorBio Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of HanchorBio?

The ISIN recorded for HanchorBio Inc. is KYG4277B1068.

Does aibio.space cover HanchorBio?

aibio.space lists HanchorBio Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to HanchorBio?

Companies in our directory listed in the same country and business area as HanchorBio: EirGenix, Anbogen Therapeutics, LAUNXP BIOMEDICAL CO., LTD., Plandai Biotechnology, Lukas biomedical, Sunhawk Vision Biotech.

Investor discussion: HanchorBio

Members talk about HanchorBio (7827). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Press releases

Headlines of HanchorBio's own announcements, newest first. Each opens the full release on the newswire that carried it.

Oct 30, 2026PR Newswire
Beyond Conventional Anti-TIGIT: HanchorBio Secures Taiwan TFDA Approval for HCB303 Following U.S. FDA Clearance

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TWSE:7827 on TradingView.

Listing details

Company: HanchorBio Inc.
Ticker: 7827
Listing: TWSE
Country or territory: Taiwan
Business scope: Biotechnology
ISIN: KYG4277B1068
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction